GlaxoSmithKline Readies Candidates to Replace Human Genome's Board -Reuters
July 03 2012 - 5:08PM
Dow Jones News
GlaxoSmithKline PLC (GSK) has prepared candidates to replace
Human Genome Sciences Inc.'s (HGSI) board, Reuters reported
Tuesday, citing a source familiar with the situation.
GSK's next move will depend on how Human Genome's sale process
pans out, the source told Reuters.
Reuters on May 30 reported that Glaxo planned to nominate 12
directors to replace Human Genome's board and had begun its search
for candidates.
After Human Genome rejected Glaxo's takeover offer, Glaxo took
its $2.6 billion bid directly to Human Genome shareholders through
a tender offer.
Full story at
http://www.reuters.com/article/2012/07/03/us-humangenome-gsk-board-idUSBRE8620ZT20120703
Write to nymonitoring@dowjones.com
Human Genome Sciences (NASDAQ:HGSI)
Historical Stock Chart
From Mar 2024 to Apr 2024
Human Genome Sciences (NASDAQ:HGSI)
Historical Stock Chart
From Apr 2023 to Apr 2024